Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Landbridge Co LLC. (Class A) | David N. Capobianco | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 18 Nov 2025 | 2,500,000 | 48,593,505 | - | 0 | Class B shares | |
| Landbridge Co LLC. (Class A) | David N. Capobianco | Director, Ten Percent Owner | 18 Nov 2025 | 2,500,000 | 48,593,505 | - | - | DBR Land Holdings LLC Units | ||
| Landbridge Co LLC. (Class A) | David N. Capobianco | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 18 Nov 2025 | 2,500,000 | 0 | - | 70 | 175,000,000 | Class A shares |
| Landbridge Co LLC. (Class A) | David N. Capobianco | Director, Ten Percent Owner | 18 Nov 2025 | 2,500,000 | 2,500,000 | - | 0 | Class A shares | ||
| Informatica Inc (Class A) | Amit Walia | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 1,773,882 | 0 | - | - | Class A Common Stock | |
| Informatica Inc (Class A) | Amit Walia | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 1,500,000 | 0 | - | - | Stock Option (right to buy) | |
| Venture Global Inc (Class A) | Fory Musser | Senior VP, Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.79 per share. | 18 Nov 2025 | 768,762 | 768,762 | - | 0.8 | 607,322 | Class A Common Stock |
| Venture Global Inc (Class A) | Fory Musser | Senior VP, Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 768,762 | 2,751,569 | - | - | Stock Options | |
| Venture Global Inc (Class A) | Fory Musser | Senior VP, Development | Sale of securities on an exchange or to another person at price $ 8.01 per share. | 18 Nov 2025 | 768,762 | 0 | - | 8.0 | 6,157,784 | Class A Common Stock |
| Informatica Inc (Class A) | Michael I. McLaughlin | EVP & Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 712,385 | 0 | - | - | Class A Common Stock | |
| Informatica Inc (Class A) | Bruce R. Chizen | Director, Chair | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 614,583 | 0 | - | - | Class A Common Stock | |
| Figure Technology Solutions | Michael Benjamin Tannenbaum | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.27 per share. | 18 Nov 2025 | 611,344 | 4,019,512 | - | 39.3 | 24,004,728 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 18 Nov 2025 | 600,000 | 9,442,260 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 18 Nov 2025 | 600,000 | 785,181 | - | - | Class A Common Stock | ||
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.96 per share. | 18 Nov 2025 | 596,356 | 6,472,696 | - | 5.0 | 2,957,926 | Class A Common Stock |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.93 per share. | 18 Nov 2025 | 596,356 | 7,069,052 | - | 4.9 | 2,940,035 | Class A Common Stock |
| Benitec Biopharma Inc | Sophie Mukadam | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 500,000 | 500,000 | - | - | Options (right to buy) | |
| Informatica Inc (Class A) | Bruce R. Chizen | Director, Chair | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 468,874 | 0 | - | - | Class A Common Stock | |
| Benitec Biopharma Inc | Jerel A. Banks | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 450,000 | 450,000 | - | - | Options (right to buy) | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 400,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 400,000 | 0 | - | - | Stock Option (right to buy) | |
| Informatica Inc (Class A) | Ansa Sekharan | EVP & Chief Customer Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 355,111 | 0 | - | - | Class A Common Stock | |
| Informatica Inc (Class A) | John Schweitzer | EVP & Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 309,204 | 0 | - | - | Class A Common Stock | |
| Informatica Inc (Class A) | Ansa Sekharan | EVP & Chief Customer Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 300,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 275,000 | 275,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 275,000 | 0 | - | - | Stock Option (right to buy) | |
| Informatica Inc (Class A) | John Schweitzer | EVP & Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 247,602 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 223,000 | 223,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 223,000 | 0 | - | - | Stock Option (right to buy) | |
| Informatica Inc (Class A) | Amit Walia | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 213,181 | 0 | - | - | Stock Option (right to buy) | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.27 per share. | 18 Nov 2025 | 212,608 | 214,779,163 (32%) | 0% | 1.3 | 271,075 | Common Stock |
| MP Materials Corp | James H. Litinsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 63.72 per share. | 18 Nov 2025 | 207,691 | 13,410,385 | - | 63.7 | 13,234,071 | Common Stock |
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 12.51 per share. | 18 Nov 2025 | 201,785 | 1,251,383 | - | 12.5 | 2,524,431 | Class A Common Stock |
| Benitec Biopharma Inc | Megan Boston | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 200,000 | 200,000 | - | - | Options (right to buy) | |
| Origin Materials Inc | John Bissell | Director, CEO and Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Nov 2025 | 200,000 | 2,042,973 | - | 0 | Common Stock | |
| Informatica Inc (Class A) | Bruce R. Chizen | Director, Chair | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 198,863 | 0 | - | - | Stock Option (right to buy) | |
| Informatica Inc (Class A) | Gerald D. Held | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 198,845 | 0 | - | - | Class A Common Stock | |
| Figure Technology Solutions | Michael Benjamin Tannenbaum | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 38.42 per share. | 18 Nov 2025 | 198,510 | 4,630,856 | - | 38.4 | 7,626,377 | Class A Common Stock |
| Medical Properties Trust Inc | Edward K. Aldag | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Nov 2025 | 194,600 | 5,079,412 (0%) | 0% | 0 | Common stock, par value $0.001 | |
| Venture Global Inc (Class A) | Fory Musser | Senior VP, Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 188,337 | 2,563,232 | - | - | Stock Options | |
| Venture Global Inc (Class A) | Fory Musser | Senior VP, Development | Sale of securities on an exchange or to another person at price $ 7.80 per share. | 18 Nov 2025 | 188,337 | 0 | - | 7.8 | 1,469,029 | Class A Common Stock |
| Venture Global Inc (Class A) | Fory Musser | Senior VP, Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.79 per share. | 18 Nov 2025 | 188,337 | 188,337 | - | 0.8 | 148,786 | Class A Common Stock |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 18 Nov 2025 | 187,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 18 Nov 2025 | 187,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 18 Nov 2025 | 187,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 18 Nov 2025 | 187,500 | 17,910,867 (26%) | 0% | 37.0 | 6,941,888 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 18 Nov 2025 | 187,500 | 18,098,367 (26%) | 0% | 37.0 | 6,941,888 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 18 Nov 2025 | 187,500 | 18,285,867 (26%) | 0% | 37.0 | 6,941,888 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 18 Nov 2025 | 187,500 | 18,285,867 (26%) | 0% | 37.0 | 6,941,888 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 18 Nov 2025 | 187,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 18 Nov 2025 | 187,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 18 Nov 2025 | 187,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 18 Nov 2025 | 187,500 | 17,910,867 (26%) | 0% | 37.0 | 6,941,888 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 18 Nov 2025 | 187,500 | 18,098,367 (26%) | 0% | 37.0 | 6,941,888 | Common Stock | |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 180,000 | 0 | - | - | Stock Option (right to buy) | |
| Informatica Inc (Class A) | Amit Walia | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 170,000 | 0 | - | - | Stock Option (right to buy) | |
| Informatica Inc (Class A) | Amit Walia | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 170,000 | 0 | - | - | Stock Option (right to buy) | |
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | 18 Nov 2025 | 166,441 | 1,453,168 | - | 0 | Class A Common Stock | ||
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | 18 Nov 2025 | 166,441 | 8,194,018 | - | - | Class B Common Stock | ||
| Tetra Tech Inc | Dan L. Batrack | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 164,285 | 404,962 (0%) | 0% | 0 | COMMON STOCK | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 160,000 | 160,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 160,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 160,000 | 160,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 160,000 | 0 | - | - | Stock Option (right to buy) | |
| HP Inc. | Enrique J. Lores | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 159,983 | 0 | - | - | Performance Adjusted Restricted Stock Units | |
| HP Inc. | Enrique J. Lores | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 159,983 | 159,986 (0%) | 0% | 0 | Common Stock | |
| WM Tech Inc (Class A) | Douglas Francis | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.83 per share. | 18 Nov 2025 | 158,733 | 8,570,806 | - | 0.8 | 131,891 | Class A Common Stock |
| Klaviyo Inc - Ordinary Shares - Series A | Andrew Bialecki | Director, Chief Executive Officer, Ten Percent Owner | 18 Nov 2025 | 147,329 | 147,329 | - | - | Series A Common Stock | ||
| Klaviyo Inc - Ordinary Shares - Series A | Andrew Bialecki | Director, Chief Executive Officer, Ten Percent Owner | 18 Nov 2025 | 147,329 | 73,845,613 | - | - | Series B Common Stock | ||
| Klaviyo Inc - Ordinary Shares - Series A | Andrew Bialecki | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.16 per share. | 18 Nov 2025 | 147,329 | 0 | - | 27.2 | 4,001,456 | Series A Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 146,914 | 880,836 (2%) | 0% | 0 | Common Stock | |
| Oncology Institute Inc | Gabriel Ling | Director | Other type of transaction at price $ 0.00 per share. | 18 Nov 2025 | 141,149 | 250,206 | - | - | Common Stock | |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 140,000 | 140,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 140,000 | 0 | - | - | Stock Option (right to buy) | |
| Griffon Corp | Ronald J. Kramer | Director, Chairman of the Board and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 136,864 | 2,026,161 (4%) | 0% | 0 | Common Stock | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 130,000 | 130,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 130,000 | 0 | - | - | Stock Option (right to buy) | |
| Biosig Tech Inc | Donald F. Browne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 125,000 | 228,345 (0%) | 0% | 0 | Common Stock | |
| Stubhub Holdings Inc | Eric Howard Baker | Director, See Remarks, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.06 per share. | 18 Nov 2025 | 122,214 | 12,291,737 | - | 12.1 | 1,473,901 | Class A Common Stock |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 18 Nov 2025 | 112,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 18 Nov 2025 | 112,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 18 Nov 2025 | 112,500 | 1,125,000 (1%) | 0% | 37.0 | 4,165,133 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 18 Nov 2025 | 112,500 | 1,237,500 (1%) | 0% | 37.0 | 4,165,133 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 18 Nov 2025 | 112,500 | 1,350,000 (1%) | 0% | 37.0 | 4,165,133 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 18 Nov 2025 | 112,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 18 Nov 2025 | 112,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 18 Nov 2025 | 112,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 18 Nov 2025 | 112,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 18 Nov 2025 | 112,500 | 1,125,000 (1%) | 0% | 37.0 | 4,165,133 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 18 Nov 2025 | 112,500 | 1,237,500 (1%) | 0% | 37.0 | 4,165,133 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 18 Nov 2025 | 112,500 | 1,350,000 (1%) | 0% | 37.0 | 4,165,133 | Common Stock | |
| INmune Bio Inc | Marcia Allen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Marcia Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 108,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 108,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 108,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 108,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 108,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 108,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 108,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 104,000 | 104,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 104,000 | 0 | - | - | Stock Option (right to buy) | |
| Informatica Inc (Class A) | Ansa Sekharan | EVP & Chief Customer Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 100,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 100,000 | 0 | - | - | Stock Option (right to buy) | |
| Fossil Grp Inc | Franco Fogliato | Director, CEO | Purchase of securities on an exchange or from another person at price $ 1.82 per share. | 18 Nov 2025 | 100,000 | 1,950,000 (3%) | 0% | 1.8 | 182,000 | Common Stock |
| Cohen & Steers Inc | Martin Cohen | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Nov 2025 | 100,000 | 8,071,461 (16%) | 0% | 0 | Common Stock | |
| Cytosorbents Corp | Phillip P. Chan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.64 per share. | 18 Nov 2025 | 100,000 | 1,482,963 (4%) | 0% | 0.6 | 64,000 | Common Stock |
| FTC Solar Inc | David Springer | Director | Sale of securities on an exchange or to another person at price $ 8.98 per share. | 18 Nov 2025 | 100,000 | 689,222 | - | 9.0 | 898,000 | Common Stock |
| WM Tech Inc (Class A) | Brian Camire | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 0.84 per share. | 18 Nov 2025 | 90,979 | 1,842,862 | - | 0.8 | 76,604 | Class A Common Stock |
| Tetra Tech Inc | Dan L. Batrack | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.69 per share. | 18 Nov 2025 | 90,653 | 314,309 (0%) | 0% | 35.7 | 3,235,406 | COMMON STOCK |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 36.50 per share. | 18 Nov 2025 | 90,336 | 208,616 | - | 36.5 | 3,297,571 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 36.49 per share. | 18 Nov 2025 | 87,705 | 404,468 | - | 36.5 | 3,200,382 | Class A Common Stock |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 18 Nov 2025 | 83,556 | 214,932,875 (32%) | 0% | 1.3 | 107,369 | Common Stock |
| Sacks Parente Golf Inc | Brett Hoge | Director | Purchase of securities on an exchange or from another person at price $ 1.07 per share. | 18 Nov 2025 | 83,000 | 231,371 | - | 1.1 | 89,125 | Common Stock |
| Informatica Inc (Class A) | Gerald D. Held | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 82,978 | 0 | - | - | Stock Option (right to buy) | |
| MP Materials Corp | James H. Litinsky | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.51 per share. | 18 Nov 2025 | 78,700 | 333,644 | - | 58.5 | 4,604,737 | Common Stock |
| QuantumScape Corp (Class A) | Kevin Hettrich | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.04 per share. | 18 Nov 2025 | 78,424 | 1,513,043 | - | 13.0 | 1,022,774 | Class A Common Stock |
| QuantumScape Corp (Class A) | Mohit Singh | CHIEF DEVELOPMENT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.04 per share. | 18 Nov 2025 | 78,013 | 1,342,041 | - | 13.0 | 1,017,414 | Class A Common Stock |
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.04 per share. | 18 Nov 2025 | 76,565 | 1,287,708 | - | 13.0 | 998,530 | Class A Common Stock |
| HP Inc. | Enrique J. Lores | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.71 per share. | 18 Nov 2025 | 76,139 | 83,847 (0%) | 0% | 22.7 | 1,729,117 | Common Stock |
| Grindr Inc (Class A) | James Fu Bin Lu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.65 per share. | 18 Nov 2025 | 75,748 | 22,388,867 | - | 13.6 | 1,033,960 | Common Stock |
| Therealreal Inc | Todd A. Suko | Chief Legal Officer and Secret | Sale of securities on an exchange or to another person at price $ 14.08 per share. | 18 Nov 2025 | 75,693 | 711,054 (0%) | 0% | 14.1 | 1,065,682 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.07 per share. | 18 Nov 2025 | 75,633 | 220,937 | - | 16.1 | 1,215,627 | Common Stock |
| INmune Bio Inc | Cory Randall Ellspermann | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Cory Randall Ellspermann | Interim CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 75,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 70,663 | 70,663 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 70,663 | 0 | - | - | Stock Option (right to buy) | |
| UNIFI Inc | Edmund M. Ingle | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 70,392 | 343,350 (1%) | 0% | 0 | Common Stock | |
| INmune Bio Inc | Cory Randall Ellspermann | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Cory Randall Ellspermann | Interim CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 70,000 | 0 | - | - | Stock Option (right to buy) | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 18 Nov 2025 | 69,728 | 214,848,891 (32%) | 0% | 1.3 | 89,252 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 68,740 | 334,659 (0%) | 0% | 0 | Common Stock | |
| Figure Technology Solutions | Michael Benjamin Tannenbaum | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.97 per share. | 18 Nov 2025 | 68,512 | 3,951,000 | - | 40.0 | 2,738,507 | Class A Common Stock |
| Griffon Corp | Robert F. Mehmel | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 68,432 | 842,217 (1%) | 0% | 0 | Common Stock | |
| BTCS Inc | Charles W. Allen | Director, CEO | Purchase of securities on an exchange or from another person at price $ 2.89 per share. | 18 Nov 2025 | 67,501 | 4,666,506 | - | 2.9 | 195,078 | Common Stock |
| Informatica Inc (Class A) | Janice Durbin Chaffin | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 66,830 | 0 | - | - | Class A Common Stock | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 18 Nov 2025 | 66,635 | 214,503,083 (32%) | 0% | 1.3 | 83,627 | Common Stock |
| UNIFI Inc | Albert P. Carey | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 63,576 | 295,834 (1%) | 0% | 0 | Common Stock | |
| Biosig Tech Inc | Ferdinand Groenewald | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 60,000 | 295,000 (1%) | 0% | 0 | Common Stock | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 59,337 | 59,337 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | David J. Moss | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 59,337 | 0 | - | - | Stock Option (right to buy) | |
| QuantumScape Corp (Class A) | Michael O. McCarthy | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.04 per share. | 18 Nov 2025 | 59,108 | 1,158,687 | - | 13.0 | 770,863 | Class A Common Stock |
| Gogo Inc | Charles C. Townsend | Director | Purchase of securities on an exchange or from another person at price $ 6.87 per share. | 18 Nov 2025 | 58,763 | 137,458 (0%) | 0% | 6.9 | 403,578 | Common Stock |
| Informatica Inc (Class A) | Bruce R. Chizen | Director, Chair | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 56,818 | 0 | - | - | Stock Option (right to buy) | |
| Fossil Grp Inc | Joe T. Martin | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 1.78 per share. | 18 Nov 2025 | 56,180 | 185,761 (0%) | 0% | 1.8 | 100,000 | Common Stock |
| CNH Industrial NV | Suzanne Heywood | Director | Purchase of securities on an exchange or from another person at price $ 9.52 per share. | 18 Nov 2025 | 52,522 | 619,427 (6%) | 0% | 9.5 | 500,009 | Common Shares |
| Acuren Corp Ltd | Richard Tong | General Counsel | Sale of securities on an exchange or to another person at price $ 9.58 per share. | 18 Nov 2025 | 52,467 | 0 | - | 9.6 | 502,634 | Common Stock |
| Informatica Inc (Class A) | Jill A. Ward | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 50,000 | 0 | - | - | Stock Option (right to buy) | |
| Franklin Resources Inc | Charles B. Johnson | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 21.49 per share. | 18 Nov 2025 | 50,000 | 90,087,677 (18%) | 0% | 21.5 | 1,074,475 | Common Stock, par value $.10 |
| Fossil Grp Inc | Franco Fogliato | Director, CEO | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 18 Nov 2025 | 50,000 | 1,850,000 (3%) | 0% | 1.8 | 87,500 | Common Stock |
| Fossil Grp Inc | Franco Fogliato | Director, CEO | Purchase of securities on an exchange or from another person at price $ 1.80 per share. | 18 Nov 2025 | 50,000 | 1,800,000 (3%) | 0% | 1.8 | 90,000 | Common Stock |
| Cohen & Steers Inc | Martin Cohen | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 59.69 per share. | 18 Nov 2025 | 50,000 | 899,205 (1%) | 0% | 59.7 | 2,984,500 | Common Stock |
| Heritage Insurance Holdings Inc | Richard A. Widdicombe | Director, Chairman | Sale of securities on an exchange or to another person at price $ 29.40 per share. | 18 Nov 2025 | 50,000 | 449,047 (1%) | 0% | 29.4 | 1,470,085 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.32 per share. | 18 Nov 2025 | 49,956 | 170,981 | - | 16.3 | 815,297 | Common Stock |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 18 Nov 2025 | 49,590 | 214,436,448 (32%) | 0% | 1.3 | 61,988 | Common Stock |
| Informatica Inc (Class A) | Jill A. Ward | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 48,845 | 0 | - | - | Class A Common Stock | |
| Figure Technology Solutions | David Todd Stevens | Chief Capital Officer | Sale of securities on an exchange or to another person at price $ 39.33 per share. | 18 Nov 2025 | 48,646 | 545,270 | - | 39.3 | 1,913,490 | Class A Common Stock |
| Cisco | Mark Patterson | EVP and CFO | Sale of securities on an exchange or to another person at price $ 77.16 per share. | 18 Nov 2025 | 48,632 | 229,180 (0%) | 0% | 77.2 | 3,752,620 | Common Stock |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.26 per share. | 18 Nov 2025 | 46,700 | 214,549,783 (32%) | 0% | 1.3 | 58,842 | Common Stock |
| Oncology Institute Inc | Mark L. Pacala | Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 18 Nov 2025 | 46,630 | 174,971 | - | 4 | 186,520 | Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 36.10 per share. | 18 Nov 2025 | 46,037 | 355,695 | - | 36.1 | 1,662,088 | Class A Common Stock |
| Post Holdings Inc | Robert V. Vitale | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 45,367 | 964,927 (1%) | 0% | 0 | Common Stock | |
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | 18 Nov 2025 | 44,923 | 1,573,785 | - | - | Class B Common Stock | ||
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 12.51 per share. | 18 Nov 2025 | 44,923 | 0 | - | 12.5 | 562,018 | Class A Common Stock |
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | 18 Nov 2025 | 44,923 | 44,923 | - | 0 | Class A Common Stock | ||
| Informatica Inc (Class A) | Francis Santiago | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 43,851 | 0 | - | - | Class A Common Stock | |
| Venture Global Inc (Class A) | Fory Musser | Senior VP, Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 42,901 | 2,520,331 | - | - | Stock Options | |
| Venture Global Inc (Class A) | Fory Musser | Senior VP, Development | Sale of securities on an exchange or to another person at price $ 7.80 per share. | 18 Nov 2025 | 42,901 | 0 | - | 7.8 | 334,628 | Class A Common Stock |
| Venture Global Inc (Class A) | Fory Musser | Senior VP, Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.79 per share. | 18 Nov 2025 | 42,901 | 42,901 | - | 0.8 | 33,892 | Class A Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.94 per share. | 18 Nov 2025 | 42,566 | 3,439,538 | - | 0.9 | 40,012 | Common Stock |
| Informatica Inc (Class A) | Janice Durbin Chaffin | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 42,553 | 0 | - | - | Stock Option (right to buy) | |
| Blue Owl Cap Corp | Craig W. Packer | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 11.75 per share. | 18 Nov 2025 | 41,600 | 41,600 (0%) | 0% | 11.8 | 488,962 | Common Stock |
| Blue Owl Cap Corp | Craig W. Packer | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 11.75 per share. | 18 Nov 2025 | 41,600 | 41,600 (0%) | 0% | 11.8 | 488,962 | Common Stock |
| MP Materials Corp | James H. Litinsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 64.60 per share. | 18 Nov 2025 | 40,720 | 13,369,665 | - | 64.6 | 2,630,512 | Common Stock |
| INmune Bio Inc | Cory Randall Ellspermann | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Cory Randall Ellspermann | Interim CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 40,000 | 0 | - | - | Stock Option (right to buy) | |
| AMC Networks Inc (Class A) | Dan McDermott | Chief Content Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 39,165 | 39,165 | - | - | Restricted Stock Units | |
| Accelerant Holdings (Class A) | Francis James O’Neill | Co-Founder, Chief U/W Officer | Purchase of securities on an exchange or from another person at price $ 13.34 per share. | 18 Nov 2025 | 38,000 | 7,235,125 | - | 13.3 | 506,810 | Class A Common Shares |
| Upwork Inc | Erica Gessert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 37,500 | 225,000 | - | - | Restricted Stock Units | |
| Upwork Inc | Erica Gessert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 37,500 | 256,105 (0%) | 0% | - | Common Stock | |
| Informatica Inc (Class A) | Gerald D. Held | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 37,234 | 0 | - | - | Stock Option (right to buy) | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 36.13 per share. | 18 Nov 2025 | 36,564 | 172,052 | - | 36.1 | 1,320,937 | Class A Common Stock |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 43.11 per share. | 18 Nov 2025 | 35,965 | 680,275 (0%) | 0% | 43.1 | 1,550,275 | Common Stock |
| Liquidia Corp | Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 30.03 per share. | 18 Nov 2025 | 35,656 | 174,998 (0%) | 0% | 30.0 | 1,070,710 | Common Stock |
| Tempus AI Inc (Class A) | Eric P. Lefkofsky | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 71.63 per share. | 18 Nov 2025 | 35,362 | 16,719,607 | - | 71.6 | 2,532,980 | Class A Common Stock |
| Liquidia Corp | Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.89 per share. | 18 Nov 2025 | 35,291 | 210,289 (0%) | 0% | 5.9 | 207,864 | Common Stock |
| Liquidia Corp | Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 35,291 | 0 | - | - | Incentive Stock Option (right to buy) | |
| INmune Bio Inc | Marcia Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Marcia Allen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Marcia Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Marcia Allen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| Hinge Health Inc (Class A) | James Budge | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.84 per share. | 18 Nov 2025 | 34,903 | 525,248 | - | 40.8 | 1,425,439 | Class A Common Stock |
| Fastly Inc (Class A) | Artur Bergman | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.68 per share. | 18 Nov 2025 | 34,829 | 2,975,730 (4%) | 0% | 10.7 | 371,974 | Class A Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 18 Nov 2025 | 33,776 | 3,482,104 | - | 0.9 | 31,412 | Common Stock |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 18 Nov 2025 | 33,572 | 214,966,448 (32%) | 0% | 1.3 | 43,308 | Common Stock |
| Agilent Tech | Padraig McDonnell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 33,340 | 69,028 (0%) | 0% | 0 | Common Stock | |
| Informatica Inc (Class A) | Bruce R. Chizen | Director, Chair | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 33,144 | 0 | - | - | Stock Option (right to buy) | |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 32,648 | 143,656 (0%) | 0% | 0 | Common Stock | |
| INmune Bio Inc | Marcia Allen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 32,500 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Marcia Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 32,500 | 32,500 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 32,500 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 32,500 | 32,500 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 32,500 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 32,500 | 32,500 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 32,500 | 32,500 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 32,500 | 0 | - | - | Stock Option (right to buy) | |
| Richardson Electronics Ltd | Edward J. Richardson | Director, Chairman & CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Nov 2025 | 32,500 | 23,114 (0%) | 0% | 0 | Common Stock | |
| Gogo Inc | Charles C. Townsend | Director | Purchase of securities on an exchange or from another person at price $ 7.17 per share. | 18 Nov 2025 | 31,228 | 168,686 (0%) | 0% | 7.2 | 223,948 | Common Stock |
| INmune Bio Inc | Cory Randall Ellspermann | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Cory Randall Ellspermann | Interim CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Cory Randall Ellspermann | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Cory Randall Ellspermann | Interim CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| PLAYSTUDIOS Inc (Class A) | Scott Peterson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.65 per share. | 18 Nov 2025 | 30,000 | 365,517 | - | 0.7 | 19,500 | Class A Common Stock |
| PLAYSTUDIOS Inc (Class A) | Scott Peterson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 18 Nov 2025 | 30,000 | 395,517 | - | 0.7 | 20,100 | Class A Common Stock |
| HP Inc. | David P. McQuarrie | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 29,671 | 85,594 (0%) | 0% | 0 | Common Stock | |
| HP Inc. | David P. McQuarrie | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 29,671 | 0 | - | - | Performance Adjusted Restricted Stock Units | |
| Figure Technology Solutions | Michael Benjamin Tannenbaum | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.12 per share. | 18 Nov 2025 | 29,634 | 3,921,366 | - | 41.1 | 1,218,461 | Class A Common Stock |
| Cytek BioSciences Inc | Wenbin Jiang | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 29,002 | 5,368,065 | - | - | Common Stock | |
| Cytek BioSciences Inc | Wenbin Jiang | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 29,002 | 386,699 | - | - | Restricted Stock Units | |
| Silvaco Grp Inc | Walden C. Rhines | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.07 per share. | 18 Nov 2025 | 29,000 | 92,818 | - | 4.1 | 118,166 | Common Stock |
| Tapestry | Todd Kahn | CEO and Brand President, Coach | Sale of securities on an exchange or to another person at price $ 102.83 per share. | 18 Nov 2025 | 29,000 | 86,736 (0%) | 0% | 102.8 | 2,982,070 | Common Stock |
| Jamf Holding Corp | David Rudow | CFO | Sale of securities on an exchange or to another person at price $ 12.85 per share. | 18 Nov 2025 | 28,850 | 413,427 | - | 12.9 | 370,861 | Common Stock |
| Mobile infra Corp | Stephanie Hogue | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 28,442 | 165,911 | - | 0 | Common Stock | |
| HP Inc. | Julie M. Jacobs | Chief Legal Officer and GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 28,067 | 0 | - | - | Performance Adjusted Restricted Stock Units | |
| HP Inc. | Julie M. Jacobs | Chief Legal Officer and GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 28,067 | 258,151 (0%) | 0% | 0 | Common Stock | |
| Fastly Inc (Class A) | Artur Bergman | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.23 per share. | 18 Nov 2025 | 27,999 | 3,010,559 (4%) | 0% | 10.2 | 286,430 | Class A Common Stock |
| Informatica Inc (Class A) | Ansa Sekharan | EVP & Chief Customer Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 27,469 | 0 | - | - | Stock Option (right to buy) | |
| Tetra Tech Inc | Leslie L. Shoemaker | EVP, Chief Sustainability | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 27,384 | 337,923 (0%) | 0% | 0 | COMMON STOCK | |
| Tetra Tech Inc | Steven M. Burdick | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 27,384 | 161,048 (0%) | 0% | 0 | COMMON STOCK | |
| Informatica Inc (Class A) | Mitesh Dhruv | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 27,289 | 0 | - | - | Class A Common Stock | |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 27,200 | 217,600 | - | - | Employee Stock Option (right to buy) | |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.18 per share. | 18 Nov 2025 | 27,200 | 716,240 (0%) | 0% | 23.2 | 630,496 | Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 36.54 per share. | 18 Nov 2025 | 27,000 | 81,000 | - | 36.5 | 986,656 | Class A Common Stock |
| ATI Inc | Robert S. Wetherbee | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 98.80 per share. | 18 Nov 2025 | 26,998 | 246,538 (0%) | 0% | 98.8 | 2,667,402 | Common Stock, par value $0.10 per share |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 36.54 per share. | 18 Nov 2025 | 26,750 | 81,250 | - | 36.5 | 977,490 | Class A Common Stock |
| Braze Inc (Class A) | William Magnuson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.64 per share. | 18 Nov 2025 | 26,698 | 694,746 | - | 26.6 | 711,235 | Class A Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.89 per share. | 18 Nov 2025 | 26,411 | 3,413,127 | - | 0.9 | 23,506 | Common Stock |
| Twist Bioscience Corp | Paula Green | SVP of Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 26,200 | 168,387 (0%) | 0% | 0 | Common Stock | |
| GoPro Inc (Class A) | Jason Christopher Stephen | VP, GC and Corporate Secretary | Sale of securities on an exchange or to another person at price $ 1.52 per share. | 18 Nov 2025 | 26,011 | 143,714 (0%) | 0% | 1.5 | 39,565 | Class A Common Stock |
| Tempus AI Inc (Class A) | Eric P. Lefkofsky | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 66.33 per share. | 18 Nov 2025 | 25,866 | 16,786,722 | - | 66.3 | 1,715,692 | Class A Common Stock |
| Twist Bioscience Corp | Dennis Cho | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 25,465 | 146,159 (0%) | 0% | 0 | Common Stock | |
| Sensus Healthcare Inc | Joseph Sardano | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 4.03 per share. | 18 Nov 2025 | 25,000 | 1,200,293 | - | 4.0 | 100,750 | Common Stock |
| Blue Owl Cap Corp | Logan Nicholson | President | Purchase of securities on an exchange or from another person at price $ 11.75 per share. | 18 Nov 2025 | 25,000 | 55,032 (0%) | 0% | 11.7 | 293,690 | Common Stock |
| Cloudastructure Inc (Class A) | Richard Bentley | Ten Percent Owner, Founder | Sale of securities on an exchange or to another person at price $ 1.05 per share. | 18 Nov 2025 | 25,000 | 200,000 | - | 1.1 | 26,250 | Class A Common Stock |
| Cloudastructure Inc (Class A) | Richard Bentley | Ten Percent Owner, Founder | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 18 Nov 2025 | 25,000 | 225,000 | - | 1.2 | 28,750 | Class A Common Stock |
| Tempus AI Inc (Class A) | Eric P. Lefkofsky | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 65.59 per share. | 18 Nov 2025 | 24,881 | 16,812,588 | - | 65.6 | 1,631,945 | Class A Common Stock |
| Tapestry | David E. Howard | Chief Legal Officer, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.50 per share. | 18 Nov 2025 | 24,795 | 30,559 (0%) | 0% | 102.5 | 2,541,488 | Common Stock |
| ATI Inc | Robert S. Wetherbee | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 98.21 per share. | 18 Nov 2025 | 24,711 | 273,536 (0%) | 0% | 98.2 | 2,426,867 | Common Stock, par value $0.10 per share |
| UNIFI Inc | Hongjun Ning | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 24,360 | 24,360 | - | - | Restricted Stock Units | |
| Medpace Holdings Inc | August J. Troendle | Director, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 592.07 per share. | 18 Nov 2025 | 23,862 | 862,315 (2%) | 0% | 592.1 | 14,127,974 | Common Stock |
| Post Holdings Inc | Nicolas Catoggio | PRES & CEO, PCB | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 23,196 | 82,059 (0%) | 0% | 0 | Common Stock | |
| MSC Industrial Direct Co. Inc (Class A) | Mitchell Jacobson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 84.96 per share. | 18 Nov 2025 | 22,870 | 2,328,192 (5%) | 0% | 85.0 | 1,943,037 | Class A Common Stock |
| Cohen & Steers Inc | Martin Cohen | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 59.50 per share. | 18 Nov 2025 | 22,633 | 921,838 (1%) | 0% | 59.5 | 1,346,664 | Common Stock |
| Bankwell Fin Grp Inc | Christopher R. Gruseke | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 22,500 | 22,500 (0%) | 0% | 0 | Common Stock | |
| Post Holdings Inc | Robert V. Vitale | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 22,411 | 987,338 (1%) | 0% | 0 | Common Stock | |
| Informatica Inc (Class A) | Gerald D. Held | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 22,340 | 0 | - | - | Stock Option (right to buy) | |
| Stubhub Holdings Inc | Nayaab Islam | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.06 per share. | 18 Nov 2025 | 22,300 | 8,193,663 | - | 12.1 | 268,938 | Class A Common Stock |
| Starz Entertainment Corp | Jeffrey A. Hirsch | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 11.40 per share. | 18 Nov 2025 | 22,172 | 198,690 | - | 11.4 | 252,761 | Common Shares |
| UNIFI Inc | Brian D. Moore | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 22,104 | 70,735 (0%) | 0% | 0 | Common Stock | |
| Cytek BioSciences Inc | Wenbin Jiang | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 22,100 | 5,347,760 | - | - | Common Stock | |
| Cytek BioSciences Inc | Wenbin Jiang | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 22,100 | 206,273 | - | - | Restricted Stock Units | |
| BigBear.ai Holdings Inc | Dorothy D. Hayes | Director | Sale of securities on an exchange or to another person at price $ 6.08 per share. | 18 Nov 2025 | 22,000 | 236,150 | - | 6.1 | 133,870 | Common Stock |
| Tetra Tech Inc | Roger R. Argus | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 21,902 | 49,651 (0%) | 0% | 0 | COMMON STOCK | |
| Tetra Tech Inc | Preston Hopson | EVP, Chief Legal/Human Capital | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 21,902 | 88,616 (0%) | 0% | 0 | COMMON STOCK | |
| UNIFI Inc | Andrew James Eaker | EVP, CFO, & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 21,420 | 90,790 (0%) | 0% | 0 | Common Stock | |
| UNIFI Inc | Meredith S. Boyd | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 21,420 | 88,276 (0%) | 0% | 0 | Common Stock | |
| Sunrise Realty Trust Inc | Leonard M. Tannenbaum | Director, Executive Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.39 per share. | 18 Nov 2025 | 21,408 | 2,998,226 | - | 9.4 | 201,021 | Common Stock |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 21,000 | 0 | - | - | Stock Option (right to buy) | |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.38 per share. | 18 Nov 2025 | 21,000 | 28,202 (0%) | 0% | 25.4 | 532,980 | Common Stock, par value $0.01 per share |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.40 per share. | 18 Nov 2025 | 21,000 | 49,202 (0%) | 0% | 8.4 | 176,400 | Common Stock, par value $0.01 per share |
| Oklo Inc (Class A) | William Carroll Murphy Goodwin | Chief Legal & Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 20,686 | 20,686 | - | - | Class A Common Stock | |
| Oklo Inc (Class A) | William Carroll Murphy Goodwin | Chief Legal & Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 20,686 | 144,798 | - | - | Restricted Stock Units | |
| Cisco | Mark Patterson | EVP and CFO | Sale of securities on an exchange or to another person at price $ 77.63 per share. | 18 Nov 2025 | 20,284 | 208,896 (0%) | 0% | 77.6 | 1,574,580 | Common Stock |
| Cartesian Therapeutics Inc | Michael Singer | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Nov 2025 | 20,000 | 53,533 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Mark A. Goldsmith | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 70.38 per share. | 18 Nov 2025 | 20,000 | 247,863 (0%) | 0% | 70.4 | 1,407,586 | Common Stock |
| Revolution Medicines Inc | Mark A. Goldsmith | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 20,000 | 137,708 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Mark A. Goldsmith | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 18 Nov 2025 | 20,000 | 267,863 (0%) | 0% | 4.1 | 81,800 | Common Stock |
| BTCS Inc | Charles W. Allen | Director, CEO | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 18 Nov 2025 | 19,499 | 4,599,005 | - | 2.9 | 56,547 | Common Stock |
| Lightpath Tech Inc (Class A) | Steven Eric Creviston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 19,355 | 171,412 (0%) | 0% | - | Class A common stock | |
| Lightpath Tech Inc (Class A) | Kimberly Crider | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 19,355 | 69,151 (0%) | 0% | - | Class A common stock | |
| Glaukos Corp | Joseph E. Gilliam | PRESIDENT & COO | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 18 Nov 2025 | 19,340 | 92,366 (0%) | 0% | 90 | 1,740,600 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 19,133 | 150,867 | - | - | Employee Stock Option (right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.24 per share. | 18 Nov 2025 | 19,133 | 158,034 (0%) | 0% | 19.2 | 368,119 | Common Stock |
| INmune Bio Inc | Marcia Allen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 19,025 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Marcia Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 19,025 | 19,025 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 19,025 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 19,025 | 19,025 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 19,025 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 19,025 | 19,025 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 19,025 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 19,025 | 19,025 | - | - | Stock Option (right to buy) | |
| Tetra Tech Inc | Dan L. Batrack | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 19,015 | 19,010 | - | - | RESTRICTED STOCK UNITS (RIGHT TO RECEIVE) | |
| Tetra Tech Inc | Dan L. Batrack | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 19,015 | 258,912 (0%) | 0% | 0 | COMMON STOCK | |
| Figure Technology Solutions | David Todd Stevens | Chief Capital Officer | Sale of securities on an exchange or to another person at price $ 38.43 per share. | 18 Nov 2025 | 18,584 | 593,916 | - | 38.4 | 714,146 | Class A Common Stock |
| Fastly Inc (Class A) | Charles Compton | Director, CEO | Sale of securities on an exchange or to another person at price $ 10.23 per share. | 18 Nov 2025 | 18,455 | 640,858 (0%) | 0% | 10.2 | 188,795 | Class A Common Stock |
| Upwork Inc | Hayden Brown | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 18,333 | 1,132,740 (0%) | 0% | - | Common Stock | |
| Upwork Inc | Hayden Brown | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 18,333 | 91,667 | - | - | Restricted Stock Units | |
| Tetra Tech Inc | Dan L. Batrack | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.69 per share. | 18 Nov 2025 | 18,235 | 240,677 (0%) | 0% | 35.7 | 650,807 | COMMON STOCK |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.40 per share. | 18 Nov 2025 | 18,000 | 46,202 (0%) | 0% | 8.4 | 151,200 | Common Stock, par value $0.01 per share |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 18,000 | 21,000 | - | - | Stock Option (right to buy) | |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.28 per share. | 18 Nov 2025 | 18,000 | 28,202 (0%) | 0% | 25.3 | 455,040 | Common Stock, par value $0.01 per share |
| Federated Hermes Inc (Class B) | J. Christopher Donahue | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 18 Nov 2025 | 18,000 | 444,288 (0%) | 0% | 3 | 54,000 | Class B Common Stock |
| Federated Hermes Inc (Class B) | John B. Fisher | Director, Vice President | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 18 Nov 2025 | 18,000 | 471,253 (0%) | 0% | 3 | 54,000 | Class B Common Stock |
| Federated Hermes Inc (Class B) | Thomas R. Donahue | Director, VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 18 Nov 2025 | 18,000 | 592,948 (0%) | 0% | 3 | 54,000 | Class B Common Stock |
| Federated Hermes Inc (Class B) | Paul A. Uhlman | Vice President | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 18 Nov 2025 | 18,000 | 333,930 (0%) | 0% | 3 | 54,000 | Class B Common Stock |
| Federated Hermes Inc (Class B) | Peter J. Germain | EVP, CLO & Sec. | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 18 Nov 2025 | 18,000 | 224,324 (0%) | 0% | 3 | 54,000 | Class B Common Stock |
| Federated Hermes Inc (Class B) | Theodore W. Zierden | Vice President | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 18 Nov 2025 | 18,000 | 155,577 (0%) | 0% | 3 | 54,000 | Class B Common Stock |
| Sunrise Realty Trust Inc | Leonard M. Tannenbaum | Director, Executive Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.45 per share. | 18 Nov 2025 | 17,790 | 2,973,226 | - | 9.5 | 168,116 | Common Stock |
| Enovix Corp | Rajendra K. Talluri | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. | 18 Nov 2025 | 17,617 | 2,295,310 | - | 7.5 | 132,128 | Common Stock |
| Post Holdings Inc | Matthew J. Mainer | EVP, CFO & TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 17,338 | 67,416 (0%) | 0% | 0 | Common Stock | |
| Informatica Inc (Class A) | Ansa Sekharan | EVP & Chief Customer Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 17,251 | 0 | - | - | Stock Option (right to buy) | |
| Post Holdings Inc | Diedre J. Gray | EVP, GC & CAO, SECY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 17,104 | 64,737 (0%) | 0% | 0 | Common Stock | |
| AFC Gamma Inc | Daniel Neville | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.81 per share. | 18 Nov 2025 | 17,000 | 226,649 | - | 2.8 | 47,770 | Common Stock |
| Herbalife Nutrition Ltd | Lynda Cloud | Director | Purchase of securities on an exchange or from another person at price $ 8.97 per share. | 18 Nov 2025 | 17,000 | 38,857 (0%) | 0% | 9.0 | 152,490 | Common Stock |
| Post Holdings Inc | Mark Westphal | PRES., FOODSERVICE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 16,682 | 194,513 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Robert F. Werner | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 16,324 | 67,194 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.42 per share. | 18 Nov 2025 | 16,000 | 16,000 (0%) | 0% | 24.4 | 390,720 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 16,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| INmune Bio Inc | Marcia Allen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 15,975 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Marcia Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 15,975 | 15,975 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 15,975 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 15,975 | 15,975 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 15,975 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 15,975 | 15,975 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 15,975 | 15,975 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 15,975 | 0 | - | - | Stock Option (right to buy) | |
| Aflac Inc | Audrey Boone Tillman | Sr. Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.97 per share. | 18 Nov 2025 | 15,862 | 246,550 (0%) | 0% | 29.0 | 459,443 | Common Stock |
| Aflac Inc | Audrey Boone Tillman | Sr. Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 15,862 | 0 | - | - | Employee Stock Option (right to buy) | |
| Aflac Inc | Audrey Boone Tillman | Sr. Executive Vice President | Sale of securities on an exchange or to another person at price $ 112.00 per share. | 18 Nov 2025 | 15,862 | 230,688 (0%) | 0% | 112 | 1,776,544 | Common Stock |
| Tempus AI Inc (Class A) | Eric P. Lefkofsky | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 72.20 per share. | 18 Nov 2025 | 15,138 | 16,704,469 | - | 72.2 | 1,092,964 | Class A Common Stock |
| Tetra Tech Inc | Leslie L. Shoemaker | EVP, Chief Sustainability | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.69 per share. | 18 Nov 2025 | 15,112 | 322,811 (0%) | 0% | 35.7 | 539,347 | COMMON STOCK |
| Tetra Tech Inc | Steven M. Burdick | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.69 per share. | 18 Nov 2025 | 15,112 | 145,936 (0%) | 0% | 35.7 | 539,347 | COMMON STOCK |
| Informatica Inc (Class A) | Gerald D. Held | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 15,000 | 0 | - | - | Stock Option (right to buy) | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 18 Nov 2025 | 15,000 | 214,564,783 (32%) | 0% | 1.3 | 18,975 | Common Stock |
| Sacks Parente Golf Inc | Brett Hoge | Director | Purchase of securities on an exchange or from another person at price $ 1.16 per share. | 18 Nov 2025 | 15,000 | 246,371 | - | 1.2 | 17,471 | Common Stock |
| Upwork Inc | Hayden Brown | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 14,850 | 1,114,407 (0%) | 0% | - | Common Stock | |
| Upwork Inc | Hayden Brown | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 14,850 | 74,250 | - | - | Restricted Stock Units | |
| Cohen & Steers Inc | Martin Cohen | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 59.91 per share. | 18 Nov 2025 | 14,659 | 936,497 (1%) | 0% | 59.9 | 878,221 | Common Stock |
| Braze Inc (Class A) | Astha Malik | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 26.64 per share. | 18 Nov 2025 | 14,322 | 219,338 | - | 26.6 | 381,538 | Class A Common Stock |
| Phillips 66 | Brian M. Mandell | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.48 per share. | 18 Nov 2025 | 14,100 | 70,937 (0%) | 0% | 78.5 | 1,106,498 | Common Stock |
| Phillips 66 | Brian M. Mandell | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 14,100 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Phillips 66 | Brian M. Mandell | Executive Vice President | Sale of securities on an exchange or to another person at price $ 137.40 per share. | 18 Nov 2025 | 14,100 | 56,837 (0%) | 0% | 137.4 | 1,937,365 | Common Stock |
| Tetra Tech Inc | Dan L. Batrack | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 14,030 | 239,897 (0%) | 0% | 0 | COMMON STOCK | |
| Tetra Tech Inc | Dan L. Batrack | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 14,030 | 0 | - | - | RESTRICTED STOCK UNITS (RIGHT TO RECEIVE) | |
| Sierra Bancorp | William Wade | EVP/Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 13,990 | 13,990 (0%) | 0% | 0 | Common Stock | |
| Tapestry | David E. Howard | Chief Legal Officer, Secretary | Sale of securities on an exchange or to another person at price $ 102.50 per share. | 18 Nov 2025 | 13,856 | 55,354 (0%) | 0% | 102.5 | 1,420,240 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 18 Nov 2025 | 13,834 | 85,026 (0%) | 0% | 11 | 152,174 | Common Stock |
| Figure Technology Solutions | David Todd Stevens | Chief Capital Officer | Sale of securities on an exchange or to another person at price $ 39.93 per share. | 18 Nov 2025 | 13,405 | 531,865 | - | 39.9 | 535,227 | Class A Common Stock |
| Revolution Medicines Inc | Jeff Cislini | General Counsel | Sale of securities on an exchange or to another person at price $ 70.14 per share. | 18 Nov 2025 | 13,388 | 50,425 (0%) | 0% | 70.1 | 939,008 | Common Stock |
| Revolution Medicines Inc | Jeff Cislini | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.45 per share. | 18 Nov 2025 | 13,388 | 63,813 (0%) | 0% | 42.5 | 568,321 | Common Stock |
| Revolution Medicines Inc | Jeff Cislini | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 13,388 | 0 | - | - | Stock Option (Right to Buy) | |
| Rekor Systems Inc | Debra Shakerdge-hennessy | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.00 per share. | 18 Nov 2025 | 13,272 | 100,053 (0%) | 0% | 2 | 26,544 | Common Stock |
| Cytek BioSciences Inc | William McCombe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 13,051 | 84,910 | - | - | Common Stock | |
| Cytek BioSciences Inc | William McCombe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 13,051 | 174,014 | - | - | Restricted Stock Units | |
| HP Inc. | David P. McQuarrie | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.71 per share. | 18 Nov 2025 | 12,941 | 72,653 (0%) | 0% | 22.7 | 293,890 | Common Stock |
| Upwork Inc | Hayden Brown | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 17.24 per share. | 18 Nov 2025 | 12,732 | 1,107,894 (0%) | 0% | 17.2 | 219,506 | Common Stock |
| Cohen & Steers Inc | Martin Cohen | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 60.83 per share. | 18 Nov 2025 | 12,708 | 949,205 (1%) | 0% | 60.8 | 773,028 | Common Stock |
| HP Inc. | Julie M. Jacobs | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.71 per share. | 18 Nov 2025 | 12,659 | 245,192 (0%) | 0% | 22.7 | 287,486 | Common Stock |
| Heritage Commerce Corp | Thomas A. Sa | Executive Vice President / COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 12,554 | 25,110 | - | - | Restricted Stock Unit | |
| Heritage Commerce Corp | Thomas A. Sa | Executive Vice President / COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 12,554 | 33,057 (0%) | 0% | 0 | Common Stock, No Par Value | |
| INmune Bio Inc | Marcia Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Marcia Allen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 12,500 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | J. Kelly Ganjei | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 12,500 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 12,500 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Timothy Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 12,500 | 0 | - | - | Stock Option (right to buy) | |
| Richardson Electronics Ltd | Edward J. Richardson | Director, Chairman & CEO, Ten Percent Owner | 18 Nov 2025 | 12,500 | 1,996,657 | - | - | Class B Common Stock | ||
| Richardson Electronics Ltd | Edward J. Richardson | Director, Chairman & CEO, Ten Percent Owner | 18 Nov 2025 | 12,500 | 55,614 (0%) | 0% | 0 | Common Stock | ||
| Alarm.com Holdings Inc | Stephen Trundle | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 48.53 per share. | 18 Nov 2025 | 12,469 | 1,305,343 (2%) | 0% | 48.5 | 605,121 | Common Stock |
| Braze Inc (Class A) | Isabelle Winkles | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.64 per share. | 18 Nov 2025 | 12,422 | 263,660 | - | 26.6 | 330,922 | Class A Common Stock |
| Tempus AI Inc (Class A) | Eric P. Lefkofsky | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 70.58 per share. | 18 Nov 2025 | 12,295 | 16,754,969 | - | 70.6 | 867,781 | Class A Common Stock |
| NextNav Inc | Susan Brasse Insley | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.78 per share. | 18 Nov 2025 | 12,189 | 131,251 | - | 12.8 | 155,775 | Common Stock |
| Upwork Inc | Hayden Brown | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 16.14 per share. | 18 Nov 2025 | 12,114 | 1,120,626 (0%) | 0% | 16.1 | 195,502 | Common Stock |
| Phillips 66 | Brian M. Mandell | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 12,100 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Phillips 66 | Brian M. Mandell | Executive Vice President | Sale of securities on an exchange or to another person at price $ 138.00 per share. | 18 Nov 2025 | 12,100 | 56,837 (0%) | 0% | 138 | 1,669,800 | Common Stock |
| Phillips 66 | Brian M. Mandell | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 94.85 per share. | 18 Nov 2025 | 12,100 | 68,937 (0%) | 0% | 94.9 | 1,147,685 | Common Stock |
| Tetra Tech Inc | Roger R. Argus | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.69 per share. | 18 Nov 2025 | 12,086 | 37,565 (0%) | 0% | 35.7 | 431,349 | COMMON STOCK |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.